ArticlePDF Available

Ethnic differences in the association between depression and chronic pain: Cross sectional results from UK Biobank Clinical presentation, diagnosis, and management

Authors:

Abstract and Figures

Background: Comorbid chronic pain and depression is a challenging dyad of conditions to manage in primary care and reporting has shown to vary by ethnic group. Whether the relationship between depression and chronic pain varies by ethnicity is unclear. This study aims to explore chronic pain and depression reporting across ethnic groups and examine whether this association differs, independently of potential confounding factors. Methods: Cross-sectional study of UK Biobank participants with complete data on chronic pain and probable lifetime history of depression, who reported their ethnic group as White, Asian/Asian British or Black/Black British. Chronic pain classification: present if participants had ≥ 1 site of body pain (up to seven sites or "pain all over the body" could be selected) that lasted ≥ 3 months; extent of chronic pain categories: 0, 1, 2-3, 4-7 sites or pain all over the body. Probable depression classification: an algorithm of low mood, anhedonia and help-seeking behaviour. Relationship between depression and presence/extent of chronic pain assessed using logistic/multinomial regression models (odds ratio (OR); relative risk ratio (RRR), 95 % confidence intervals), adjusted for sociodemographic, lifestyle, and morbidity factors; and a final adjustment for current depressive symptoms. Results: The number of participants eligible for inclusion was 144,139: 35,703 (94 %) White, 4539 (3 %) Asian, and 3897 (3 %) Black. Chronic pain was less (40.5 %, 45.8 %, 45.0 %, respectively) and depression more (22.1 %, 12.9 %, 13.8 %, respectively) commonly reported in White participants than Asian and Black participants. Statistically significant associations between depression and presence/extent of chronic pain persisted following adjustment for potential confounding variables; this relationship was strongest for Black participants (presence of chronic pain: OR 1.86 (1.52, 2.27); RRR 1 site 1.49 (1.16, 1.91), 2-3 sites 1.98 (1.53, 2.56), 4-7 sites 3.23 (2.09, 4.99), pain all over the body 3.31 (2.05, 5.33). When current depressive symptoms were considered these relationships were attenuated. Conclusions: Chronic pain and depression reporting varies across ethnic groups. Differences in health seeking behaviour between ethnic groups may impact on the results reported. Clinicians, particularly in primary care, need to be aware of the cultural barriers within certain ethic groups to expressing concern over mood and to consider their approach accordingly.
Content may be subject to copyright.
R E S E A R C H A R T I C L E Open Access
Ethnic differences in the association
between depression and chronic pain:
cross sectional results from UK Biobank
Barbara I. Nicholl
1*
, Daniel J. Smith
1
, Breda Cullen
1
, Daniel Mackay
1
, Jonathan Evans
1
, Jana Anderson
1
,
Donald M. Lyall
1
, Chloe Fawns-Ritchie
2
, Andrew M. McIntosh
3
, Ian J. Deary
2
, Jill P. Pell
1
and Frances S. Mair
1
Abstract
Background: Comorbid chronic pain and depression is a challenging dyad of conditions to manage in primary
care and reporting has shown to vary by ethnic group. Whether the relationship between depression and chronic
pain varies by ethnicity is unclear. This study aims to explore chronic pain and depression reporting across ethnic
groups and examine whether this association differs, independently of potential confounding factors.
Methods: Cross-sectional study of UK Biobank participants with complete data on chronic pain and probable
lifetime history of depression, who reported their ethnic group as White, Asian/Asian British or Black/Black British.
Chronic pain classification: present if participants had 1 site of body pain (up to seven sites or pain all over the
bodycould be selected) that lasted 3 months; extent of chronic pain categories: 0, 1, 23, 47 sites or pain all
over the body. Probable depression classification: an algorithm of low mood, anhedonia and help-seeking
behaviour. Relationship between depression and presence/extent of chronic pain assessed using logistic/
multinomial regression models (odds ratio (OR); relative risk ratio (RRR), 95 % confidence intervals), adjusted for
sociodemographic, lifestyle, and morbidity factors; and a final adjustment for current depressive symptoms.
Results: The number of participants eligible for inclusion was 144,139: 35,703 (94 %) White, 4539 (3 %) Asian, and
3897 (3 %) Black. Chronic pain was less (40.5 %, 45.8 %, 45.0 %, respectively) and depression more (22.1 %, 12.9 %,
13.8 %, respectively) commonly reported in White participants than Asian and Black participants. Statistically
significant associations between depression and presence/extent of chronic pain persisted following adjustment for
potential confounding variables; this relationship was strongest for Black participants (presence of chronic pain: OR
1.86 (1.52, 2.27); RRR 1 site 1.49 (1.16, 1.91), 23 sites 1.98 (1.53, 2.56), 47 sites 3.23 (2.09, 4.99), pain all over the
body 3.31 (2.05, 5.33). When current depressive symptoms were considered these relationships were attenuated.
Conclusions: Chronic pain and depression reporting varies across ethnic groups. Differences in health seeking
behaviour between ethnic groups may impact on the results reported. Clinicians, particularly in primary care, need
to be aware of the cultural barriers within certain ethic groups to expressing concern over mood and to consider
their approach accordingly.
Keywords: Chronic pain, Depression, Ethnicity, Comorbidity
* Correspondence: Barbara.Nicholl@glasgow.ac.uk
1
Institute of Health & Wellbeing, University of Glasgow, Glasgow, UK
Full list of author information is available at the end of the article
© 2015 Nicholl et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Nicholl et al. BMC Family Practice (2015) 16:128
DOI 10.1186/s12875-015-0343-5
Content courtesy of Springer Nature, terms of use apply. Rights reserved.
Background
Chronic musculoskeletal pain and depression are com-
mon, complex disorders that are challenging to treat and
manage in primary care. They often co-occur and long-
standing debate has surrounded the temporal nature of
the relationship between chronic pain and depression
and on the causes and consequences of this relationship
[1]. Factors affecting the presentation and management
of symptoms are wide-ranging and will involve a com-
bination of demographic, personal, lifestyle, environmen-
tal and social elements.
Population-based studies have shown that self-reported
musculoskeletal pain is more prevalent among ethnic mi-
nority groups in the UK, particularly widespread pain at
multiple sites of the body [24]. In the US, the prevalence
of self-reported pain is higher in Hispanic and Black eth-
nic groups than non-Hispanic White individuals [5]; how-
ever, this difference was not apparent after adjusting for
potential confounders such as sociodemographic status,
comorbidity, and psychological distress. Minority ethnic
groups in US pain clinic populations have also reported
more severe or disabling pain than the non-Hispanic
White population in the US [6, 7]. Recent studies in the
US have focused on trying to better explain the racial and
ethnic disparities in pain treatment and management, and
suggest that access to healthcare, and patient attitudes and
behaviours may play a role in explaining some of the dis-
parities observed [810]. Similarly, ethnic minority groups
have also been reported to be less likely to seek profes-
sional help for mood problems [11] yet the prevalence of
depression is reported to be higher in these groups in the
UK than in the majority White ethnic group [12, 13].
Few studies have specifically considered the comorbid-
ity of chronic pain and depression across ethnic groups,
rather ethnicity has been considered as a covariate in the
relationship between pain and depression or as a pre-
dictor of pain and depression [14]. In a study of 866 par-
ticipants, Miller and Cano (2009) found that African
Americans were almost twice as likely to have comorbid
depression and pain as Caucasian Americans, relative to
those with no pain or depression [15]. However, it is
unclear whether similar patterns would be observed
amongst other ethnic groups and whether the relation-
ship between depression and pain is similar in US and
UK ethnic groups.
Chronic pain and depression have also been shown to
be some of the most common comorbidities in individuals
with other physical and mental long-term conditions
[1618]. Given the ethnic [19, 20] and sociodemographic
[16] gradient evident in the pattern of long-term condition
reporting it is important to study the relationship between
socioeconomic status, ethnicity, pain, and depression in-
dependently of other physical long-term conditions, and
furthermore understand whether a history of depression
or current depressive symptoms are more important. De-
veloping an understanding of these relationships has the
potential to impact on how health professionals manage
chronic pain in primary care, particularly for ethnic mi-
nority groups that may be less likely to present with their
low mood problems.
The overall aim of this study is to determine: 1) the
prevalence of chronic pain and depression by ethnic
group; and two) whether the relationship between depres-
sion and chronic pain varies by ethnicity, using data from
UK Biobank. Here we report on differences in the preva-
lence of chronic pain and depression, and in the associ-
ation between depression and pain across ethnic groups,
independently of potential confounding factors, including
sociodemographic, lifestyle, and morbidity factors.
Methods
This study utilises baseline cross-sectional data from UK
Biobank (http://www.ukbiobank.ac.uk/). UK Biobank is a
large cohort study of over 500,000 persons aged 4070
years across England, Scotland, and Wales. Individuals
registered with the National Health Service and living
within a 25 mile radius of one of 22 UK Biobank assess-
ment centres were invited to participate [21]. Participa-
tion involved completion of touch-screen questionnaires
and nurse-led interviews to collect epidemiological data
on demographic, health, environmental and lifestyle fac-
tors. Questions on mood disorder were added part-way
during recruitment and the 172,745 participants who
completed the detailed questions on lifetime features of
mood disorders were eligible for inclusion in this study.
Ethnic groups
Participants were asked in the touch screen questionnaire
What is your ethnic group?Response options were:
White, Mixed, Asian or Asian British, Black or Black
British, Chinese, and other ethnic group. Due to insuffi-
cient numbers in the other ethnic groups, only those
whoconsideredthemselvesasWhite,AsianorAsian
British (including Indian, Pakistani, Bangladeshi and any
other Asian background), and Black or Black British
(including Caribbean, African and any other Black back-
ground) were included in this study; these groups will be
referred to in this manuscript as White, Asian, and Black
ethnic groups.
Classification of chronic pain
Within UK Biobank, participants were asked whether
they had experienced pain in the past month that inter-
fered with their usual activities, in any of the following
sites: headache, facial, neck or shoulder, back, stomach
or abdominal, hip, and knee; and an eighth option of
pain all over the body. Multiple sites could be selected,
unless participants reported pain all over the body. For
Nicholl et al. BMC Family Practice (2015) 16:128 Page 2 of 10
Content courtesy of Springer Nature, terms of use apply. Rights reserved.
all sites selected a subsequent question asked whether
the pain had been present for more than three months.
Chronic pain was defined as pain that had persisted for
more than three months. The presence of chronic pain
was classified if participants reported any site of chronic
pain; those reporting no sites of chronic pain were clas-
sified as being free of chronic pain. The extent of
chronic pain was calculated by summing the number of
sites of chronic pain reported and the following categor-
ies were defined: free of chronic pain; chronic pain at
one site; chronic pain at 23 sites; chronic pain at 47
sites; and pain all over the body. This classification of
number of pain sites has previously been reported [22].
Classification of depression
The definition of probable lifetime depression history
among UK Biobank participants has been described in
detail previously [23]. Using the touch screen question-
naire, participants answered questions regarding their past
history of mood disorder symptoms and related medical
help-seeking, which were similar to questions within the
Structured Clinical Interview for DSM-IV Axis I Disorders
[24]. Probable major depressive disorder included partici-
pants that we classified as having a lifetime history of
recurrent severe, recurrent moderate or single episode
depression; the criteria for these definitions are outlined
in Fig. 1. Current depressive symptom score was calcu-
lated from four individual questions that assessed the fre-
quency of the following depression symptoms over the
past 2 weeks: depressed mood, unenthusiasm/disinterest,
tenseness/restlessness, and tiredness/lethargy. Questions
were answered on a four point scale: not at all; several
days; more than half the days; and nearly every day. Indi-
vidual answers were summed to give a score of 012 for
each participant; with higher scores reflecting greater
levels of current depressive symptoms. This score was in-
dependent of the classification of lifetime depression sta-
tus described above and in Fig. 1.
Potential confounding variables
Sociodemographic, lifestyle and morbidity factors are
associated with both depression and chronic pain.
Alongside age and sex, Townsend Score, an area level
measure of deprivation based on the participants
postcode of residence [25], was used to describe the
sociodemographic profile of the study population.
Quintiles of the Townsend score were generated for
the study population; quintile 1 represents the least
deprived and quintile 5 the most deprived areas.
Current smoking status (never, current, or former
smokers) and frequency of alcohol consumption
(daily/almost daily, 34 times per week, 12times
per week, 13 times per month, special occasions
only and never) were self-reported. Body mass index
(BMI) was calculated from height and weight mea-
surements taken at the assessment centre and cate-
gorised as underweight (<18.5 kg/m
2
), normal weight
(18.524.9 kg/m
2
), overweight (25.029.9 kg/m
2
), and
obese (30.0 kg/m
2
) to describe the population but
was treated as a continuous variable in the regression
analysis. A count of self-reported, non-cancer long-
term conditions was generated from the information
provided during the nurse interview. Inclusion of
conditions was based on previous literature [16], au-
thor experience (FM) and a UK Biobank prevalence
of 0.1 %. Painful and psychiatric conditions were ex-
cluded from the count for this study, resulting in 36
conditions being included in the count.
Ethical approval
Electronic, informed consent was given in person at the
assessment centre before participation in the study. This
study forms part of UK Biobank project 7155 and UK
Biobank has full ethical approval from NHS National
Research Ethics Service (approval letter dated 17 June
2011, Ref 11/NW/0382).
Fig. 1 Detailed description of the classification of a probable lifetime history of depression using available data fields in UK Biobank; a positive
classification for probable lifetime depression included all three depression categories: single, recurrent (moderate), and recurrent (severe)
Nicholl et al. BMC Family Practice (2015) 16:128 Page 3 of 10
Content courtesy of Springer Nature, terms of use apply. Rights reserved.
Statistical analysis
Chronic pain, depression, and comorbid pain and de-
pression prevalence are reported for each ethnic group,
along with sociodemographic, lifestyle and morbidity
variables. Chi squared tests for categorical variables and
Kruskal Wallis tests for continuous variables are used to
assess differences between ethnic groups for each of the
pain, depression and potential confounding variables. To
quantify the association between depression and the
presence of chronic pain, logistic regression models were
used; results are presented as odds ratios (OR) and 95 %
confidence intervals. To quantify the association be-
tween depression and the extent of chronic pain re-
ported, multinomial logistic regression models were
used; results are presented as relative risk ratios (RRR)
and 95 % confidence intervals. The association between
depression (independent variable) and chronic pain
(dependent variable) was quantified using a separate re-
gression model for each ethnic group as we were specif-
ically interested in the relationship between depression
and chronic pain within ethnic groups. Interaction be-
tween depression and ethnicity with both chronic pain
outcomes was assessed and was indicated for some sub-
groups at approximately p= 0.10. For both chronic pain
outcomes (presence and extent of chronic pain), levels
of adjustment for the regression models were as follows:
1) univariate analysis (no adjustment); 2) adjusted for
sociodemographic variables age, sex and quintiles of
Townsend score; 3) adjusted for sociodemographic and
lifestyle variables as in 2) plus smoking status, fre-
quency of alcohol consumption and BMI; 4) adjusted for
sociodemographic, lifestyle and morbidity count as in
3) plus number of long-term conditions reported. In
order to investigate the impact of current depressive
symptom score as this may impact on an individuals
current pain reports (and vice versa), a final adjustment
for current depressive symptom score is described in the
text. All analysis was conducted using Stata V13.0 [26].
The number of participants included in each model var-
ied according to the proportion of missing data for each
of the potential confounding variables; however, the
completion rate of confounding variables included in the
regression models was at least 99.3 %, with the exception
of current depressive symptom score, which was com-
pleted by 92.0 %.
Results
Of the 172,743 UK Biobank participants who were asked
questions on lifetime history of depression and manic
symptoms, 28,604 (16.6 %) were excluded: 22,901 (13.3 %)
provided incomplete data precluding classification of their
lifetime history of mood disorder features; 1615 (0.9 %)
had probable bipolar disorder; 3876 (2.2 %) were not in
the three main ethnic groups (or did not provide data on
their ethnicity); and 212 (0.1 %) did not provide complete
data on pain. Thus, 144,139 participants were included in
the study: 135,703 (94.1 %) were White, 4539 (3.1 %)
Asian, and 3897 (2.7 %) Black. Of the 144,139 participants,
40.8 % reported chronic pain in one or more body sites
and 21.6 % were classified as having probable lifetime his-
tory of depression; comorbid chronic pain and depression
was present in 10.9 % of included participants (Table 1).
Description of ethnic groups
Over half the participants in all three ethnic groups con-
sidered in this study reported no chronic pain (5460 %)
and approximately 23 % in all groups reported only one
site of chronic pain. A greater proportion of Asian and
Black participants reported multisite pain (23 and 47
sites) and pain all over the body compared to White par-
ticipants (Table 1). A more apparent difference in preva-
lence of lifetime history of depression was observed
across the three ethnic groups. A significantly greater
proportion of the White ethnic group were classified as
having a lifetime history of probable depression com-
pared to the Asian and Black ethnic groups (22.1 %,
12.9 % and 13.8 %, respectively). Eleven percent of
White participants reported depression without pain
compared to only 5 % of the Asian and Black groups. In
contrast, 38.4 % and 36.6 % of Asian and Black partici-
pants respectively reported chronic pain without depres-
sion, compared with 29.4 % of White participants.
Although comorbid chronic pain and depression was
more common in the White ethnic group (11.1 %) it was
the same proportion as that reporting depression only in
this group. Whereas in the Asian and Black groups, a
greater proportion reported comorbid chronic pain and
depression than depression alone.
Table 1 also summarises ethnic groups by demo-
graphic, lifestyle and morbidity factors. The Asian and
White groups included a lower proportion of females
than the Black ethnic group. A greater proportion of
both the White and Black ethnic groups reported being
former or current smokers and drinking alcohol than
the Asian ethnic group. A greater proportion of the
Asian and Black groups were classified in the most de-
prived quintile compared to the White group; these
groups were also younger than the White group. BMI
was noticeably higher in the Black ethnic group com-
pared to Asian and White groups and current depressive
symptom score was noticeably higher in the Asian and
Black groups than the White group.
Association between depression and the presence of
chronic pain
In the univariate analysis for all three ethnic groups,
having depression was associated with at least a 65 % in-
creased odds of reporting chronic pain; although this
Nicholl et al. BMC Family Practice (2015) 16:128 Page 4 of 10
Content courtesy of Springer Nature, terms of use apply. Rights reserved.
Table 1 Prevalence of chronic pain and depression overall and by ethnic group
Ethnic group
a
Overall N= 144,139 White N= 135,703 Asian N= 4539 Black N= 3897
Presence of chronic pain
b
Yes N (%) 58,785 (40.8) 54,949 (40.5) 2081 (45.8) 1755 (45.0)
Extent of chronic pain
b
0N (%) 85,354 (59.2) 80,754 (59.5) 2458 (54.2) 2142 (55.0)
1 32,948 (22.9) 31,040 (22.9) 1023 (22.5) 885 (22.7)
23 20,975 (14.6) 19,554 (14.4) 791 (17.4) 630 (16.2)
47 3371 (2.3) 3096 (2.3) 145 (3.2) 130 (3.3)
Pain all over the body 1491 (1.0) 1259 (0.9) 122 (2.7) 110 (2.8)
Depression (lifetime history)
b
Yes N (%) 31,080 (21.6) 29,957 (22.1) 584 (12.9) 539 (13.8)
Depression and chronic pain status
b
Free of depression and chronic pain N (%) 69,942 (48.5) 65,795 (48.5) 2214 (48.8) 1933 (49.6)
Depression only 15,412 (10.7) 14,959 (11.0) 244 (5.4) 209 (5.4)
Chronic pain only 43,117 (29.9) 39,951 (29.4) 1741 (38.4) 1425 (36.6)
Chronic pain and depression 15,668 (10.9) 14,998 (11.1) 340 (7.5) 330 (8.5)
Sex
b
Female N (%) 79,596 (53.1) 72,166 (53.2) 2122 (46.8) 2308 (59.2)
Age (years)
b
Mean (SD) 56.8 (8.1) 57.1 (8.1) 53.6 (8.6) 52.3 (8.0)
Townsend Index quintiles
Missing data N230 210 10 10
1 (least deprived) N (%) 24,482 (17.0) 24,091 (17.8) 304 (6.7) 87 (2.24)
2 29,077 (20.2) 28,557 (21.1) 351 (7.8) 169 (4.4)
3 29,978 (20.8) 28,959 (21.4) 674 (14.9) 345 (8.9)
4 32,347 (22.5) 29,760 (22.0) 1575 (34.8) 1012 (26.0)
5 (most deprived) 28,025 (19.5) 24,126 (17.8) 1625 (35.9) 2274 (58.5)
Smoking status
Missing data N445 389 35 21
Never N (%) 80,000 (55.7) 73,679 (54.5) 3544 (78.7) 2777 (71.7)
Former 53,717 (37.4) 52,184 (38.6) 718 (15.9) 815 (21.0)
Current 9977 (6.9) 9451 (7.0) 242 (5.4) 284 (7.3)
Frequency of alcohol intake
Missing data N66 44 15 7
Daily/almost daily N (%) 30,118 (20.9) 29,530 (21.8) 335 (7.4) 253 (6.5)
34 times/week 33,362 (23.2) 32,552 (24.0) 412 (9.1) 397 (10.2)
12 times/week 36,663 (25.5) 35,204 (30.0) 664 (14.7) 795 (20.4)
13 times/month 16,190 (11.2) 15,239 (11.2) 378 (8.4) 573 (14.7)
Special occasions only 16,376 (11.4) 14,388 (10.6) 876 (19.4) 1112 (28.6)
Never 11,364 (7.9) 8745 (6.5) 1859 (41.1) 760 (19.5)
BMI
Missing data N980 765 126 89
Mean (SD) 27.5 (1.8) 27.4 (4.7) 27.0 (4.4) 29.6 (5.4)
Nicholl et al. BMC Family Practice (2015) 16:128 Page 5 of 10
Content courtesy of Springer Nature, terms of use apply. Rights reserved.
relationship was greater in Asian and Black ethnic
groups. Adjusting for demographic factors in model two
had little effect on these relationships (see Table 2). Fur-
ther adjustment to include lifestyle factors did decrease
the strength of the relationship between depression and
chronic pain reporting, however,therelationshipsremained
significant. Fully adjusting the models for demographic and
lifestyle factors, and number of morbidities, attenuated the
relationships further but a significant association between
depression and the presence of chronic pain remained for
all three ethnic groups, and was strongest in the Asian and
Black ethnic groups: White (OR = 1.46, 95 % CI 1.43, 1.51),
Asian (OR = 1.53, 95 % CI 1.27, 1.85), and Black ethnic
group (OR = 1.86, 95 % CI 1.52, 2.27).
Association between depression and the extent of
chronic pain
For all three ethnic groups, the RRR between depression
and chronic pain in model one (unadjusted) increased as
the number of pain sites reported increased. The strength
of the relationship between depression and chronic pain
reporting was more apparent in both Asian and Black eth-
nic groups than in the White ethnic group, when 23pain
sites, 47 pain sites, or pain all over the body was re-
ported. This pattern of association remained through all
levels of adjustment, although the RRRs were attenuated
(Table 3). In the fully adjusted model (model 4) a dose re-
sponse relationship between depression and extent of pain
reported was evident for Asian and Black ethnic groups.
In the White ethnic group this dose response was evident
up to 47 sites of pain and then leveled off for pain all
over the body. The RRR of reporting 47 sites of pain
was 2.35 (95 % CI 2.17, 2.54) in the White ethnic group,
2.63 (95 % CI 1.67, 4.13) in the Asian ethnic group, and
3.31 (95 % CI 2.05, 5.33) in the Black ethnic group.
Impact of current depressive symptoms
Including current depressive symptom score in a final
model greatly attenuated the relationship between prob-
able depression and both the presence and extent of
chronic pain for all three ethnic groups. There was no lon-
ger a statistically significant relationship between probable
depression and presence/extent of chronic pain in Asian
participants. However, a statistically significant relationship
remained between depression and presence of chronic
pain for both the White (OR = 1.22, 95 % CI 1.19, 1.27)
and Black (OR= 1.41, 95 % CI 1.13, 1.78) ethnic groups,
and a similar pattern to model 4 (Table 3) was observed
with the extent of chronic pain for these groups.
Discussion
Our study has demonstrated that chronic pain in at least
one body site is very common, affecting more than 40 %
of our UK Biobank study population. Furthermore over
one fifth of the population were classified as having a
probable lifetime history of depression, and comorbid
chronic pain and depression was present in 11 % of in-
cluded participants. Chronic multisite pain was reported
more commonly and lifetime history of probable depres-
sion less commonly in Black and Asian ethnic groups in
UK Biobank compared to the majority White study popu-
lation. Quantification of the association between
Table 1 Prevalence of chronic pain and depression overall and by ethnic group (Continued)
Morbidity count
b
Mean (SD) 0.9 (1.0) 0.8 (1.0) 0.9 (1.1) 0.9 (1.0)
Current depressive symptom score
Missing data N11,511 10,018 833 660
Mean (SD) 1.5 (2.0) 1.4 (1.9) 2.5 (2.8) 2.2 (2.7)
SD Standard deviation; BMI Body mass index
a
Differences between groups were statistically significant at p< 0.001 for all variables (tested by Chi
2
test for categorical variables and Kruskal Wallis test for
continuous variables)
b
No missing data
Table 2 Logistic regression analysis, stratified by ethnic group, of the relationship between depression and the presence of chronic
pain
Ethnic group
Level of adjustment
a
White OR (95 % CI)* Asian OR (95 % CI)* Black OR (95 % CI)*
Model 1 - no adjustment 1.65 (1.61, 1.69) 1.77 (1.48, 2.11) 2.14 (1.78, 2.58)
Model 2 - adjusted for demographic factors 1.61 (1.57, 1.66) 1.71 (1.43, 2.05) 2.12 (1.75, 2.56)
Model 3 - adjusted for demographic and lifestyle factors 1.53 (1.45, 1.57) 1.62 (1.35, 1.95) 1.99 (1.63, 2.42)
Model 4 - adjusted for demographic, lifestyle and morbidity count 1.46 (1.43, 1.51) 1.53 (1.27, 1.85) 1.86 (1.52, 2.27)
*All individual associations and the overall models were significant at p< 0.001
a
Referent group for all models is the free of chronic pain group
Nicholl et al. BMC Family Practice (2015) 16:128 Page 6 of 10
Content courtesy of Springer Nature, terms of use apply. Rights reserved.
depression and chronic pain suggests that the relation-
ship between depression and both the presence and ex-
tent of chronic pain is stronger in the minority ethnic
groups, particularly the group comprising those of
Black ethnicity. These findings suggest that although
depression is less common in minority ethnic groups it
is more strongly associated with chronic pain, particu-
larly in Black ethnicities. However, on a formal test of
the coefficients in model 4 (suest command in Stata),
the difference between ethnic groups was not statistically
significant for the presence or extent of chronic pain,
except for the difference between the presence of chronic
pain in Black compared to White ethnic groups.
This study resonates with previous reports from much
smaller study populations of an increased prevalence of
chronic pain, including multiple sites of joint pain and
widespread pain, in UK minority ethnic groups [24].
We have also shown that there is a dose-response rela-
tionship in the association between depression and the
number of sites of pain reported across all ethnic
groups, although this pattern appears to be more
marked for the minority ethnic groups studied. To our
knowledge this is the first study to have reported this re-
lationship. The pattern of the association between de-
pression and pain all over the bodywas not consistent
across ethnic groups. Participants in Asian and Black
ethnic groups were three times more likely to report
pain all over the bodythan White participants.
Replication in a larger sample of participants from mi-
nority ethnic groups with pain all over the bodywould
be valuable. Miller and Cano reported (based on 80 par-
ticipants) that African Americans in the United States
were more likely to report comorbid depression and
chronic pain than a non-Hispanic White group [15].
However, in the current study, comorbid chronic pain
and depression reporting was more common in the
White population, which was a similar proportion to
that which reported depression only in this group
(11 %). In contrast, in the Asian and Black groups, a
greater proportion reported comorbid chronic pain and
depression (8 and 9 %, respectively) than depression
alone (5 % for both groups), suggesting that ethnic mi-
nority groups in the UK are more likely to report de-
pression alongside their pain rather than depression
alone, showing some similarity with the American study.
We have also shown that although probable lifetime
depression was reported less commonly in minority eth-
nic groups in this study; these groups did report a higher
mean current depressive symptom score compared to
the White ethnic group. Including current depressive
symptom score in the fully adjusted regression models
attenuated the relationship between probable depression
and presence/extent of chronic pain in White and Black
ethnic groups, and completely diminished the relation-
ship in the Asian ethnic group. Our definition of prob-
able lifetime depression was based on a relatively strict
Table 3 Multinomial logistic regression analysis, stratified by ethnic group, of the relationship between depression and the extent of
chronic pain
Ethnic group
Level of adjustment^ Extent of chronic pain White RRR (95 % CI) Asian RRR (95 % CI) Black RRR (95 % CI)
Model 1 no adjustment 1 pain site 1.36 (1.32, 1.40) 1.25 (0.99, 1.57)** 1.58 (1.25, 2.00)
23 pain sites 1.89 (1.82, 1.95) 1.97 (1.57, 2.47) 2.29 (1.80, 2.92)
47 pain sites 3.16 (2.94, 3.40) 3.46 (2.35, 5.09) 4.26 (2.87, 6.33)
Pain all over the body 2.96 (2.64, 3.31) 3.65 (2.41, 5.52) 4.32 (2.82, 6.61)
Model 2 - adjusted for demographic factors 1 pain site 1.35 (1.31, 1.39) 1.22 (0.97, 1.54)** 1.61 (1.27, 2.05)
23 pain sites 1.82 (1.76, 1.89) 1.92 (1.53, 2.41) 2.23 (1.74, 2.86)
47 pain sites 2.94 (2.73, 3.17) 3.30 (2.22, 4.90) 4.18 (2.78, 6.29)
Pain all over the body 2.80 (2.49, 3.14) 3.60 (2.37, 5.48) 4.05 (2.61, 6.29)
Model 3 - adjusted for demographic
and lifestyle factors
1 pain site 1.31 (1.27, 1.36) 1.16 (0.92, 1.47)** 1.52 (1.19, 1.95)*
23 pain sites 1.72 (1.66, 1.78) 1.82 (1.47, 2.34) 2.11 (1.64, 2.73)
47 pain sites 2.66 (2.47, 2.87) 3.02 (2.00, 4.58) 3.63 (2.36, 5.58)
Pain all over the body 2.48 (2.20, 2.79) 3.23 (2.08, 5.00) 4.10 (2.59, 6.50)
Model 4 adjusted for demographic,
lifestyle and morbidity count
1 pain site 1.29 (1.24, 1.33) 1.14 (0.90, 1.45)** 1.49 (1.16, 1.91)*
23 pain sites 1.63 (1.57, 1.69) 1.77 (1.40, 2.24) 1.98 (1.53, 2.56)
47 pain sites 2.35 (2.17, 2.54) 2.52 (1.65, 3.87) 3.23 (2.09, 4.99)
Pain all over the body 2.19 (1.94, 2.47) 2.63 (1.67, 4.13) 3.31 (2.05, 5.33)
All individual associations were significant at p< 0.001 except for *p0.002 and **p> 0.05
Overall models were significant at p< 0.001
^ Referent group for all models is the free of chronic pain group
Nicholl et al. BMC Family Practice (2015) 16:128 Page 7 of 10
Content courtesy of Springer Nature, terms of use apply. Rights reserved.
definition which included help-seeking behaviour as a
key criterion (Fig.1) [23]. It is therefore quite possible
that individuals from minority ethnic groups in the UK
are aware of symptoms of low mood but may not have
sought medical help for these and may be more likely to
seek help for physical symptoms. Furthermore there is
evidence to suggest that mental health problems in
Black and minority ethnic groups are less likely to be de-
tected by a GP [27, 28]. It could be hypothesised that
somatic symptoms included in the current depressive
score (tenseness/restlessness and tiredness/lethargy) may
be more highly endorsed than the psychological symp-
toms of low mood and anhedonia by individuals in the
minority ethnic groups, yet closer inspection revealed
that all items are endorsed as experienced on more
than half the daysor nearly every dayover the past
two weeks more frequently by participants from the
Asian and Black ethnic groups than the White ethnic
group. However, this tool to assess current depressive
symptoms has not been validated and the items could
potentially function differently across the three ethnic
groups in this study.
Strengths and Limitations
Major strengths of this study include the large scale of
the UK Biobank dataset of middle-aged to older adults
in England, Scotland, and Wales. We conducted this
analysis on a large subset of the UK Biobank population,
which included over 3000 participants from both Asian
and Black ethnic groups. Furthermore, participation in
UK Biobank involved detailed assessment of a large
number of demographic, lifestyle and morbidity factors,
which allowed the association between depression and
chronic pain (presence and extent) to be considered in-
dependently of potential confounders, including number
of comorbid physical long-term conditions. Multimor-
bidity has been shown to be more common in minority
ethnic groups [20]; our results suggest that the relation-
ship between depression and pain is independent of
other physical long-term conditions across all ethnic
groups although we were unable to consider the func-
tional or physical limitations caused by such conditions,
which has been shown to be important [13]. There are
further limitations to this study. The information in-
cluded in this study (except BMI) was self-reported. This
has potential implications for the reliability of the data;
however, the large sample size suggests it is unlikely that
over or under reporting of chronic pain or depressive
symptoms would impact on the results observed. The
validity of our classification of a lifetime history of prob-
able depression has previously been considered in detail
[23] and shown to be distributed as expected by socio-
economic status, gender, self-reported health, and smok-
ing. Our study was cross-sectional in nature and we are
therefore unable to determine the temporal relationship
between pain and depression reporting in this group.
Due to the smaller number of participants from mixed
(N= 1062), Chinese (N= 534) and other ethnic group
(N= 1719), participants from these groups were ex-
cluded from the current study as no meaningful conclu-
sions could have been drawn. It is known that
individuals from minority ethnic groups are less likely to
take part in medical research [29, 30]; however, it is un-
clear from UK Biobank how many individuals from mi-
nority ethnic groups were invited to take part and did
not respond. The 2011 England and Wales census re-
ported the population to be 86 % White; 7.5 % Asian or
Asian British and 3.3 % Black or Black British [31]. Our
study population comprised 94 % White, 3 % Asian or
Asian British, and 3 % Black or Black British. We have
applied exclusion criteria based on ethnicity to our study
population and therefore cannot make a direct com-
parison between our study population and the UK
population.
Our study is lacking information on the severity of the
pain reported by participants. Increasing pain severity
has been shown to correlate with an increased number
of sites of chronic pain [32] and in our study we have
shown that participants of Asian or Black ethnicity are
more likely to report multisite chronic pain, suggesting
that they may be experiencing more severe chronic pain.
Another limitation is our lack of information on; accul-
turation, the extent to which ethnic groups and individ-
uals change their culture as a result of migration
[33], which may affect beliefs and actions and influence
reporting of health issues. This has been demonstrated
previously by Choudhury et al [4] who reported that in a
study of 1223 individuals (50 % White) chronic pain and
chronic widespread pain were more prevalent in the
group who identified as being Bangladeshi (72 and 16 %,
respectively) compared to both White (56 and 10 %, re-
spectively) and British Bangladeshi (54 and 9 %, respect-
ively), living in a borough of London, England. Without
information on acculturation it may be that our esti-
mates of chronic pain prevalence are an under-
estimation of that in ethnic groups who do not identify
as being British.
Clinical implications
In the present study we were interested, not only in dif-
ferences in the prevalence and type of pain reporting
across ethnic groups, but also in the relationship be-
tween depression and chronic pain reporting; and al-
though we found only limited statistical differences
between ethnic groups for the relationship between de-
pression and chronic pain, differences in pain and de-
pression reporting across the groups were observed. Our
findings have implications for patient management,
Nicholl et al. BMC Family Practice (2015) 16:128 Page 8 of 10
Content courtesy of Springer Nature, terms of use apply. Rights reserved.
especially in primary care. Differences in coping strat-
egies, language barriers and the cultural interpretation of
pain and low mood may influence a persons likelihood
to self-report symptoms or seek medical help, and may
affect how they present in the clinical encounter, making
it more difficult for health professionals to recognise
these problems.
Ethnicity adds a further complexity to the already clin-
ically complex dyad of pain and depression. It is clear,
however, that early professional medical advice is helpful
and further consideration of a package of treatment for
the comorbid conditions is required [1] but our findings
suggest that attention should be paid to whether differ-
ent approaches may be more suitable for certain ethnic
groups. Ethnic disparities in the management of chronic
pain have received much attention in the US and studies
suggest that better strategies need to be implemented to
reduce these inequalities [810].
Conclusions
Cultural differences and language deficits can be bar-
riers to good care provision for minority ethnic groups
but so too can health professionalspoor understanding
of these barriers and of potential ethnic differences in
modes of presentation. A key question for clinicians is
how to best respond to these issues? An increased
awareness of cultural differences and their potential
implications for management is essential. Bhui and
Bhugra (2004) suggest culturally grounded explanations
of mental illness are needed [34]. This is especially im-
portant since healthcare providers are increasingly deal-
ing with ever more ethnically diverse populations and
this is likely to increase as time goes on as there are ap-
proximately 214 million migrants worldwide [35]; with
73 million currently residing in the WHO European re-
gion [36]. However, further research is needed to exam-
ine how these ethnic differences in chronic pain and
depression reporting affect long term health outcomes
and to explore whether there are differences in health
care utilisation and the type of care accessed.
Abbreviations
BMI: Body mass index; CI: Confidence interval; OR: Odds ratio; RRR: Relative
risk ratio; SD: Standard deviation.
Competing interests
The authors declare that they have no competing interests.
Authorscontributions
BN and FM conceived of the study. All authors contributed to design. BN
performed all statistical analyses. All authors agreed on analyses and
interpreted the results. BN and FM drafted the manuscript. All authors
revised the manuscript and approved the final version.
Availability of data and materials
Not applicable.
Authorsinformation
Not applicable.
Acknowledgements
This research has been conducted using the UK Biobank resource; we are
grateful to UK Biobank participants. UK Biobank was established by the
Wellcome Trust medical charity, Medical Research Council, Department of
Health, Scottish Government and the Northwest Regional Development
Agency. It has also had funding from the Welsh Assembly Government and
the British Heart Foundation.
Author details
1
Institute of Health & Wellbeing, University of Glasgow, Glasgow, UK.
2
Centre
for Cognitive Ageing and Cognitive Epidemiology, Department of
Psychology, University of Edinburgh, Edinburgh, UK.
3
Division of Psychiatry,
University of Edinburgh, Edinburgh, UK.
Received: 9 April 2015 Accepted: 18 September 2015
References
1. Linton SJ, Bergbom S. Understanding the link between depression and
pain. Scand J Pain. 2011;2(2):4754.
2. Allison TR, Symmons DP, Brammah T, Haynes P, Rogers A, Roxby M, et al.
Musculoskeletal pain is more generalised among people from ethnic
minorities than among white people in Greater Manchester. Ann Rheum
Dis. 2002;61(2):1516.
3. Palmer B, Macfarlane G, Afzal C, Esmail A, Silman A, Lunt M. Acculturation
and the prevalence of pain amongst South Asian minority ethnic groups in
the UK. Rheumatology (Oxford). 2007;46(6):100914.
4. Choudhury Y, Bremner SA, Ali A, Eldridge S, Griffiths CJ, Hussain I, et al.
Prevalence and impact of chronic widespread pain in the Bangladeshi and
White populations of Tower Hamlets. East London Clin Rheumatol.
2013;32(9):137582.
5. Reyes-Gibby CC, Aday LA, Todd KH, Cleeland CS, Anderson KO. Pain in
aging community-dwelling adults in the United States: non-Hispanic whites,
non-Hispanic blacks, and Hispanics. J Pain. 2007;8(1):7584.
6. Edwards RR, Doleys DM, Fillingim RB, Lowery D. Ethnic differences in pain
tolerance: clinical implications in a chronic pain population. Psychosom
Med. 2001;63(2):31623.
7. McCracken LM, Matthews AK, Tang TS, Cuba SL. A comparison of blacks and
whites seeking treatment for chronic pain. Clin J Pain. 2001;17(3):24955.
8. Shavers VL, Bakos A, Sheppard VB. Race, ethnicity, and pain among the U.S.
adult population. J Health Care Poor Underserved. 2010;21(1):177220.
9. Anderson KO, Green CR, Payne R. Racial and ethnic disparities in pain:
causes and consequences of unequal care. J Pain. 2009;10(12):1187204.
10. Meghani SH, Byun E, Gallagher RM. Time to take stock: a meta-analysis and
systematic review of analgesic treatment disparities for pain in the United
States. Pain Med. 2012;13(2):15074.
11. Smaje C, LeGrand J. Ethnicity, equity and the use of health services in the
British NHS. Soc Sci Med. 1997;45(3):48596.
12. Bhui K, Bhugra D, Goldberg D, Sauer J, Tylee A. Assessing the prevalence of
depression in Punjabi and english primary care attenders: the role of
culture, physical illness and somatic symptoms. Transcult Psychiatry.
2004;41(3):30722.
13. Williams ED, Tillin T, Richards M, Tuson C, Chaturvedi N, Hughes AD, et al.
Depressive symptoms are doubled in older British South Asian and Black
Caribbean people compared with Europeans: associations with excess
co-morbidity and socioeconomic disadvantage. Psychol Med. 2015;45:111.
14. Arnow BA, Hunkeler EM, Blasey CM, Lee J, Constantino MJ, Fireman B, et al.
Comorbid depression, chronic pain, and disability in primary care.
Psychosom Med. 2006;68(2):2628.
15. Miller LR, Cano A. Comorbid chronic pain and depression: who is at risk? J
Pain. 2009;10(6):61927.
16. Barnett K, Mercer SW, Norbury M, Watt G, Wyke S, Guthrie B. Epidemiology
of multimorbidity and implications for health care, research, and medical
education: a cross-sectional study. Lancet. 2012;380(9836):3743.
17. Gallacher KI, Batty G, McLean G, Mercer SW, Guthrie B, May CR, et al. Stroke,
multimorbidity and polypharmacy in a nationally representative sample of
1,424,378 patients in Scotland: implications for treatment burden. BMC Med.
2014;12(1):151.
Nicholl et al. BMC Family Practice (2015) 16:128 Page 9 of 10
Content courtesy of Springer Nature, terms of use apply. Rights reserved.
18. Smith DJ, Langan J, McLean G, Guthrie B, Mercer SW. Schizophrenia is
associated with excess multiple physical-health comorbidities but low levels
of recorded cardiovascular disease in primary care: cross-sectional study.
BMJ Open 2013, 3(4). doi10.1136/bmjopen-2013-002808. Print 2013.
19. Mathur R, Hull SA, Badrick E, Robson J. Cardiovascular multimorbidity: the
effect of ethnicity on prevalence and risk factor management. Br J Gen
Pract. 2011;61(586):e26270.
20. Lynch CP, Gebregziabher M, Axon RN, Hunt KE, Payne E, Egede LE. Geographic
and racial/ethnic variations in patterns of multimorbidity burden in patients
with type 2 diabetes. J Gen Intern Med. 2015;30(1):2532.
21. Allen N, Sudlow C, Downey P, Peakman T, Danesh J, Elliott P, et al. UK
Biobank: Current status and what it means for epidemiology. Health Policy
Technol. 2012;1(3):1236.
22. Nicholl BI, Mackay D, Cullen B, Martin DJ, Ul-Haq Z, Mair FS, et al. Chronic
multisite pain in major depression and bipolar disorder: cross-sectional
study of 149,611 participants in UK Biobank. BMC Psychiatry. 2014;14(1):350.
23. Smith DJ, Nicholl BI, Cullen B, Martin D, Ul-Haq Z, Evans J, et al. Prevalence
and characteristics of probable major depression and bipolar disorder
within UK biobank: cross-sectional study of 172,751 participants. PLoS One.
2013;8(11):e75362.
24. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview
for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition. 2002.
25. Townsend P. Deprivation. J Soc Policy. 1987;16:12546.
26. StataCorp. Stata Statistical Software: Release 13. 2013.
27. National Institute for Mental Health in England. Inside Outside: Improving
Mental Health Services for Black and Minority Ethnic Communities in
England. 2003.
28. Shaw CM, Creed F, Tomenson B, Riste L, Cruickshank JK. Prevalence of
anxiety and depressive illness and help seeking behaviour in African
Caribbeans and white Europeans: two phase general population survey.
BMJ. 1999;318(7179):3025.
29. Shavers VL, Lynch CF, Burmeister LF. Racial Differences in Factors that
Influence the Willingness to Participate in Medical Research Studies. Ann
Epidemiol. 2002;12(4):24856.
30. Choudhury Y, Hussain I, Parsons S, Rahman A, Eldridge S, Underwood M.
Methodological challenges and approaches to improving response rates in
population surveys in areas of extreme deprivation. Prim Health Care Res
Dev. 2012;13(3):2118.
31. Office for National Statistics. Ethnicity and National Identity in England and
Wales 2011. 2012.
32. Hocking LJ. Generation Scotland, Morris AD, Dominiczak AF, Porteous DJ,
Smith BH: Heritability of chronic pain in 2195 extended families. Eur J Pain.
2012;16(7):105363.
33. Berry JW. Immigration, acculturation, and adaptation. Appl Psychol.
1997;46(1):534.
34. Bhui K, Bhugra D. Communication with patients from other cultures: the
place of explanatory models. Adv Psychiatr Treat. 2004;10(6):4748.
35. International Organization for Migration. World migration facts and figures.
2013.
36. World Health Organisation. [http://www.euro.who.int/en/health-topics/
health-determinants/pages/news/news/2014/04/new-websites-on-
migration-and-roma-health] Accessed on: 16-02-2015.
Submit your next manuscript to BioMed Central
and take full advantage of:
Convenient online submission
Thorough peer review
No space constraints or color figure charges
Immediate publication on acceptance
Inclusion in PubMed, CAS, Scopus and Google Scholar
Research which is freely available for redistribution
Submit your manuscript at
www.biomedcentral.com/submit
Nicholl et al. BMC Family Practice (2015) 16:128 Page 10 of 10
Content courtesy of Springer Nature, terms of use apply. Rights reserved.
1.
2.
3.
4.
5.
6.
Terms and Conditions
Springer Nature journal content, brought to you courtesy of Springer Nature Customer Service Center GmbH (“Springer Nature”).
Springer Nature supports a reasonable amount of sharing of research papers by authors, subscribers and authorised users (“Users”), for small-
scale personal, non-commercial use provided that all copyright, trade and service marks and other proprietary notices are maintained. By
accessing, sharing, receiving or otherwise using the Springer Nature journal content you agree to these terms of use (“Terms”). For these
purposes, Springer Nature considers academic use (by researchers and students) to be non-commercial.
These Terms are supplementary and will apply in addition to any applicable website terms and conditions, a relevant site licence or a personal
subscription. These Terms will prevail over any conflict or ambiguity with regards to the relevant terms, a site licence or a personal subscription
(to the extent of the conflict or ambiguity only). For Creative Commons-licensed articles, the terms of the Creative Commons license used will
apply.
We collect and use personal data to provide access to the Springer Nature journal content. We may also use these personal data internally within
ResearchGate and Springer Nature and as agreed share it, in an anonymised way, for purposes of tracking, analysis and reporting. We will not
otherwise disclose your personal data outside the ResearchGate or the Springer Nature group of companies unless we have your permission as
detailed in the Privacy Policy.
While Users may use the Springer Nature journal content for small scale, personal non-commercial use, it is important to note that Users may
not:
use such content for the purpose of providing other users with access on a regular or large scale basis or as a means to circumvent access
control;
use such content where to do so would be considered a criminal or statutory offence in any jurisdiction, or gives rise to civil liability, or is
otherwise unlawful;
falsely or misleadingly imply or suggest endorsement, approval , sponsorship, or association unless explicitly agreed to by Springer Nature in
writing;
use bots or other automated methods to access the content or redirect messages
override any security feature or exclusionary protocol; or
share the content in order to create substitute for Springer Nature products or services or a systematic database of Springer Nature journal
content.
In line with the restriction against commercial use, Springer Nature does not permit the creation of a product or service that creates revenue,
royalties, rent or income from our content or its inclusion as part of a paid for service or for other commercial gain. Springer Nature journal
content cannot be used for inter-library loans and librarians may not upload Springer Nature journal content on a large scale into their, or any
other, institutional repository.
These terms of use are reviewed regularly and may be amended at any time. Springer Nature is not obligated to publish any information or
content on this website and may remove it or features or functionality at our sole discretion, at any time with or without notice. Springer Nature
may revoke this licence to you at any time and remove access to any copies of the Springer Nature journal content which have been saved.
To the fullest extent permitted by law, Springer Nature makes no warranties, representations or guarantees to Users, either express or implied
with respect to the Springer nature journal content and all parties disclaim and waive any implied warranties or warranties imposed by law,
including merchantability or fitness for any particular purpose.
Please note that these rights do not automatically extend to content, data or other material published by Springer Nature that may be licensed
from third parties.
If you would like to use or distribute our Springer Nature journal content to a wider audience or on a regular basis or in any other manner not
expressly permitted by these Terms, please contact Springer Nature at
onlineservice@springernature.com
... Using the terms "chronic pain, " "depression, " and "UK Biobank" in PubMed (from the inception to March 1, 2024), we found 13 studies including chronic pain and depression through the analysis of UK Biobank [19,20,[35][36][37][38][39][40][41][42][43][44][45]. Of the 13 studies, five focused on genetic information [35,36,39,41,45], five were association analyses [19,37,38,42,44], one examined the role of coffee in the association between chronic pain and depression [43], one was a clinical prediction model for the development and spread of chronic pain [20], and one assessed risk factors for facial pain [40]. ...
... Using the terms "chronic pain, " "depression, " and "UK Biobank" in PubMed (from the inception to March 1, 2024), we found 13 studies including chronic pain and depression through the analysis of UK Biobank [19,20,[35][36][37][38][39][40][41][42][43][44][45]. Of the 13 studies, five focused on genetic information [35,36,39,41,45], five were association analyses [19,37,38,42,44], one examined the role of coffee in the association between chronic pain and depression [43], one was a clinical prediction model for the development and spread of chronic pain [20], and one assessed risk factors for facial pain [40]. We also extended the search to clinical prediction models based on other datasets and found no other relevant studies. ...
Article
Full-text available
Background The prevalence of depression among people with chronic pain remains unclear due to the heterogeneity of study samples and definitions of depression. We aimed to identify sources of variation in the prevalence of depression among people with chronic pain and generate clinical prediction models to estimate the probability of depression among individuals with chronic pain. Methods Participants were from the UK Biobank. The primary outcome was a “lifetime” history of depression. The model’s performance was evaluated using discrimination (optimism-corrected C statistic) and calibration (calibration plot). Results Analyses included 24,405 patients with chronic pain (mean age 64.1 years). Among participants with chronic widespread pain, the prevalence of having a “lifetime” history of depression was 45.7% and varied (25.0–66.7%) depending on patient characteristics. The final clinical prediction model (optimism-corrected C statistic: 0.66; good calibration on the calibration plot) included age, BMI, smoking status, physical activity, socioeconomic status, gender, history of asthma, history of heart failure, and history of peripheral artery disease. Among participants with chronic regional pain, the prevalence of having a “lifetime” history of depression was 30.2% and varied (21.4–70.6%) depending on patient characteristics. The final clinical prediction model (optimism-corrected C statistic: 0.65; good calibration on the calibration plot) included age, gender, nature of pain, smoking status, regular opioid use, history of asthma, pain location that bothers you most, and BMI. Conclusions There was substantial variability in the prevalence of depression among patients with chronic pain. Clinically relevant factors were selected to develop prediction models. Clinicians can use these models to assess patients’ treatment needs. These predictors are convenient to collect during daily practice, making it easy for busy clinicians to use them.
... Our findings also reproduce known relationships from a range of socioeconomic and psychological factors. 75,90 To address the lack of specificity when categorising CP, a UK academic consortium of clinicians and pain researchers, many of whom have experience of working with UKB 75,86,130,133 (Table 1), which were fully aligned with the CP cohorts described in this paper. These focused on the most prevalent causes of CP and associated comorbidities and risk factors. ...
... Most pain studies conducted in UKB were cross-sectional because of the data being collected at a single time point. These have identified a wide range of associations with pain phenotypes including ethnicity, 90 alcohol consumption, 8,74 smoking, 74 physical activity, 91 low socioeconomic status, 1,74 cardiovascular disease, 5 type 2 diabetes (T2D), 5 number of long-term comorbidities, 83 adverse childhood experiences, 55 depression, 89,90 and bipolar disorder. 89 They have also revealed that certain anatomical features are influential in pain. ...
Article
Full-text available
Chronic pain (CP) is a common and often debilitating disorder that has major social and economic impacts. A subset of patients develop CP that significantly interferes with their activities of daily living and requires a high level of healthcare support. The challenge for treating physicians is in preventing the onset of refractory CP or effectively managing existing pain. To be able to do this, it is necessary to understand the risk factors, both genetic and environmental, for the onset of CP and response to treatment, as well as the pathogenesis of the disorder, which is highly heterogenous. However, studies of CP, particularly pain with neuropathic characteristics, have been hindered by a lack of consensus on phenotyping and data collection, making comparisons difficult. Furthermore, existing cohorts have suffered from small sample sizes meaning that analyses, especially genome-wide association studies, are insufficiently powered. The key to overcoming these issues is through the creation of large consortia such as DOLORisk and PAINSTORM and biorepositories, such as UK Biobank, where a common approach can be taken to CP phenotyping, which allows harmonisation across different cohorts and in turn increased study power. This review describes the approach that was used for studying neuropathic pain in DOLORisk and how this has informed current projects such as PAINSTORM, the rephenotyping of UK Biobank, and other endeavours. Moreover, an overview is provided of the outputs from these studies and the lessons learnt for future projects.
... Modelled aggregated ethnicity proportions for residents in each of 298 LSOAs across North Staffordshire and Stoke-on-Trent were obtained under a User Agreement from the Consumer Data Research Centre Data Service (Approved Project Reference: 749-01; van Dijk et al., 2020). Available literature and data sources from the UK suggested a higher prevalence of chronic pain and more severe and widespread pain in people from Black, Asian and other ethnic minority groups with possible exception of people identifying as Chinese ethnicity (Allison et al., 2002;Macfarlane et al., 2015;Nicholl et al., 2015;PHE, 2017;University of Essex, 2022). Multiplicative correction factors (compared to prevalence in White populations) used for chronic pain and high-impact chronic pain, respectively, were: Asian excluding Chinese (1.1, 1.2), Black (1.2, 1.5), Chinese (0.9, 0.8), Mixed/multiple (1.0, 1.1). ...
... Variables reflecting LSOAlevel ethnic diversity could not be included in the multilevel models due to a combination of missing data on ethnicity and small numbers of respondents identifying as Black, Asian or Mixed/Multiple ethnicity. We applied correction factors to reduce bias affecting LSOA prevalence estimates based on prevalence estimates by ethnic group for pain-related variables available from other publications and data sources (Allison et al., 2002;Macfarlane et al., 2015;Nicholl et al., 2015;PHE, 2017;University of Essex, 2022). For high-impact chronic pain, we chose to use the least conservative values suggested by the available resources as correction factors given some evidence of greater disparities for more severe pain. ...
Article
Full-text available
Background Chronic pain affects up to half of UK adults, impacting quality of life and demand on local health services. Whilst local health planning is currently based on subnational prevalence estimates, associations between pain and sociodemographic characteristics suggest that inequalities in the prevalence of chronic and high-impact chronic pain between neighbourhoods within local authorities are likely. We aimed to derive lower super output area (LSOA) estimates of the prevalence of chronic and high-impact chronic pain. Methods Presence of self-reported chronic and high-impact chronic pain were measured in adults aged 35+ in North Staffordshire and modelled using multilevel regression as a function of demographic and geographic predictors. Multilevel model predictions were post-stratified using the North Staffordshire age-sex population structure and LSOA demographic characteristics to estimate the prevalence of chronic and high-impact chronic pain in 298 LSOAs, corrected for ethnic diversity underrepresented in the data. Confidence intervals were generated for high-impact chronic pain using bootstrapping. Results Data were analysed from 4162 survey respondents (2358 women, 1804 men). The estimated prevalence of chronic and high-impact chronic pain in North Staffordshire LSOAs ranged from 18.6% to 50.1% and 6.18 [1.71, 16.0]% to 33.09 [13.3, 44.7]%, respectively. Conclusions Prevalence of chronic and high-impact chronic pain in adults aged 35+ varies substantially between neighbourhoods within local authorities. Further insight into small-area level variation will help target resources to improve the management and prevention of chronic and high-impact chronic pain to reduce the impact on individuals, communities, workplaces, services and the economy.
... Beyond gender, Fayez et al. (2016) reported that there is a trend toward incidence of chronic pain increasing with age; their figures for adults over 75 years of age were 62%, falling to 14.3% in young adults aged between 18 and 25. UK-based studies have reported a higher incidence of chronic pain in non-white populations (Nicholl et al., 2015); this is echoed in US-based studies . Other studies have reported a relationship between lower incomes or education levels and chronic pain -in that those with lower incomes and education levels are more likely to experience chronic pain (Nicholl et al., 2015). ...
... UK-based studies have reported a higher incidence of chronic pain in non-white populations (Nicholl et al., 2015); this is echoed in US-based studies . Other studies have reported a relationship between lower incomes or education levels and chronic pain -in that those with lower incomes and education levels are more likely to experience chronic pain (Nicholl et al., 2015). However, these studies did not differentiate between types of chronic pain, the severity of impact on the lives of those with pain, or the diagnosis they were given. ...
... In the UK, being from an ethnic minority background and living in areas of deprivation can exacerbate the likelihood and impact of chronic pain, including reduced help-seeking and access to healthcare. 51 Moreover, the association between depression and chronic pain may differ by ethnicity, 52 and people from ethnic minority backgrounds and those with lower socioeconomic status also had more negative outcomes (including higher rates of death) due to the Covid-19 coronavirus during the pandemic. 15 Regrettably, we were not able to stratify our analyses by ethnicity or socioeconomic status, but it is important to carefully consider intersectionality in future research. ...
... • In the US and UK, chronic pain has higher prevalence within racially minoritised groups, including 10% higher prevalence in black groups relative to all other ethnic groups in England. 27,73,81 • Ethnic categories are complex, historical, political and change over time, with racism increasingly recognised as a mechanism in ethnic health inequities which influences social determinants of health such as quality education, access to healthcare and the labour market. 35 • Stress associated with racism can manifest biologically, with mechanisms including: Provider bias, differences in prescribing; racial cultural stereotypes; variable access to healthcare relative to need; mistrust in the scientific process due to historical racism in scientific practices. ...
Article
Full-text available
Chronic pain is experienced unequally by different population groups; we outline examples from the pain literature of inequities related to gender, ethnicity, socioeconomic and migration status. Health inequities are systematic, avoidable and unfair differences in health outcomes between groups of people, with the fundamental ‘causes of causes’ recognised as unequal distribution of income, power and wealth. Intersectionality can add further theory to health inequities literature; collective social identities including class/socioeconomic status, race/ethnicity, gender, migration status, age, sexuality and disabled status intersect in multiple interconnected systems of power leading to differing experiences of privilege and oppression which can be understood as axes of health inequities. The process of knowledge creation in pain research is shaped by these interconnected systems of power, and may perpetuate inequities in pain care as it is largely based on majority white, middle class, Eurocentric populations. Intersectionality can inform research epistemology (ways of knowing), priorities, methodology and methods. We give examples from the literature where intersectionality has informed a justice oriented approach across different research methods and we offer suggestions for further development. The use of a reductionist frame can force unachievable objectivity on to complex health concepts, and we note increasing realisation in the field of the need to understand the individuals within their social world, and recognise the fluid and contextual nature of this.
... Participants of Studies One and Two will be purposively sampled to gain a wide range of experiences [39]. Attention will be paid to include underserved groups such as minority ethnic populations who are more likely to experience somatic symptoms related to psychological distress [40]. Potential participants will be approached via postal mail with an invitation letter. ...
Article
Full-text available
Introduction Unexplained symptoms are common across healthcare settings and are associated with increased mental and physical morbidity and healthcare expenditure. Improving the identification, explanation and management of unexplained symptoms will be helpful to patientsand healthcare systems. Limited data exists exploring unexplained acute abdominal pain in the surgical setting. Objectives This protocol describes three interlinked studies. Study one will determine the prevalence of anxiety and depression in patients presenting with explained and unexplained abdominal pain in an acute surgical setting. Study two will explore how the explanation and management of unexplained symptoms is conveyed to patients. Study three will explore how patients with unexplained symptoms understand these explanations. Methods and analysis Patients aged ≥18 years who present to a surgical same day emergency care unit with acute abdominal pain will be eligible. In study one, participants will be asked to complete a questionnaire, including validated self-report measures, at the time of presentation and six months later. They will be divided into explained and unexplained symptom groups based on clinical presentation and investigation outcomes. The proportion in each group meeting diagnostic thresholds for anxiety and depression will be compared and baseline predictors of pain and quality of life six months later will be determined. In study two, recordings of consultations between patients and surgeons involving the explanation and management of unexplained abdominal pain will be analysed. In study three, participants will be interviewed to explore their experiences and understanding of their symptoms.
Article
Chronic pain and psychiatric conditions often coexist with shared risk factors and a reverse causal link. Depression and anxiety comorbidities are associated with increased pain intensity, less favorable response to treatments, and higher medical costs. The management of psychiatric comorbidities in chronic pain conditions is less explored in India. This paper aims to review the current literature landscape of comorbid depressive and/or anxiety disorders with chronic pain conditions in the Indian populations and identify need gaps for future research. A literature search on MEDLINE database and other sources conducted from January 2010 through March 2020 retrieved 84 shortlisted eligible articles and their findings were synthesized into a narrative review. There was a high prevalence of comorbid depression and anxiety with chronic pain observed across multiple pain etiologies and population groups in the Indian setting. Women had a higher burden of psychiatric comorbidities in chronic pain conditions compared with men. Poor socioeconomic conditions and pain severity were important risk factors that predisposed individuals to psychological distress. There was limited data on evidence-based management of chronic pain and comorbid depression or anxiety for Indian populations. Barriers toward effective pain management in India occur at the level of patients, physicians, or healthcare systems; some of these challenges relate to patient's health-seeking behavior, stigma associated with psychiatric treatment, physician awareness, and education, and access to pain medications. Future initiatives are needed toward building an evidence base for effective management of pain and comorbid psychiatric conditions in India.
Article
Full-text available
Objective: Depression and chronic widespread pain (CWP) frequently coexist, but whether depression is an independent causal risk factor for CWP, and/or vice versa, remains unclear. We investigated the bidirectional causal relationship between depression and CWP. Methods: We performed a two-sample Mendelian randomisation (MR) study to estimate the causal relationship between genetically predicted depression (170,756 cases, 329,443 controls) and risk of CWP (6,914 cases, 242,929 controls), and the effect of CWP on depression susceptibility, using large population-level genetic data. We used a new MR method, Causal Analysis Using Summary Effect estimates (CAUSE), which allows for sample overlap, in addition to traditional MR and sensitivity analyses. Results: For each doubling in odds of genetic liability to depression, the risk of chronic widespread pain was increased (OR 1.004, 95% credible interval 1.003-1.005; p = 7.3 × 10-5 that the causal model is a better fit than non-causal model). There was bidirectional evidence of causality, with genetic liability to chronic widespread pain increasing depression susceptibility (OR 2.31; 95%CrI 1.57, 3.40; p = 0.0026 that the causal model is a better fit). Other MR methods produced concordant results. Conclusions: This study provides evidence in support of a bidirectional causal relationship between depression and increased risk of chronic widespread pain, whilst overcoming the major limitations of previous epidemiological studies. Interventions for depression may be an effective strategy to prevent or reduce the burden of chronic widespread pain and vice versa.
Article
Full-text available
Despite elevated risk profiles for depression among South Asian and Black Caribbean people in the UK, prevalences of late-life depressive symptoms across the UK's three major ethnic groups have not been well characterized. Data were collected at baseline and 20-year follow-up from 632 European, 476 South Asian and 181 Black Caribbean men and women (aged 58-88 years), of a community-based cohort study from north-west London. The 10-item Geriatric Depression Scale was interviewer-administered during a clinic visit (depressive symptoms defined as a score of ⩾4 out of 10), with clinical data (adiposity, diabetes, cardiovascular disease, cognitive function) also collected. Sociodemographic, psychosocial, behavioural, disability, and medical history information was obtained by questionnaire. Prevalence of depressive symptoms varied by ethnic group, affecting 9.7% of White European, 15.5% of South Asian, and 17.7% of Black Caribbean participants. Compared with White Europeans, South Asian and Black Caribbean participants were significantly more likely to have depressive symptoms (odds ratio 1.79, 95% confidence interval 1.24-2.58 and 1.80, 1.11-2.92, respectively). Adjustment for co-morbidities had most effect on the excess South Asian odds, and adjustment for socioeconomic position had most effect on the elevated Black Caribbean odds. Higher prevalence of depressive symptoms observed among South Asian people were attenuated after adjustment for physical health, whereas the Black Caribbean increased prevalence was most explained by socioeconomic disadvantage. It is important to understand the reasons for these ethnic differences to identify opportunities for interventions to address inequalities.
Article
Full-text available
Background Chronic pain has a strong association with major depressive disorder (MDD), but there is a relative paucity of studies on the association between chronic multisite pain and bipolar disorder (BD). Such studies are required to help elucidate the complex biological and psychological overlap between pain and mood disorders. The aim of this study is to investigate the relationship between chronic multisite pain and mood disorder across the unipolar-bipolar spectrum.Methods We conducted a cross-sectional study of 149,611 UK Biobank participants. Self-reported depressive and bipolar features were used to categorise participants into MDD and BD groups and a non-mood disordered comparison group. Multinomial logistic regression was used to establish whether there was an association between extent of chronic pain (independent variable) and mood disorder category (dependent variable), using no pain as the referent category, and adjusting for a wide range of potential sociodemographic, lifestyle and comorbidity confounders.ResultsMultisite pain was significantly more prevalent in participants with BD and MDD, for example, 4¿7 pain sites: BD 5.8%, MDD 4.5%, and comparison group 1.8% (p¿<¿0.001). A relationship was observed between extent of chronic pain and risk of BD and persisted after adjusting for confounders (relative to individuals with no chronic pain): 2¿3 sites RRR of BD 1.84 (95% CI 1.61, 2.11); 4¿7 sites RRR of BD 2.39 (95%CI 1.88, 3.03) and widespread pain RRR of BD 2.37 (95%CI 1.73, 3.23). A similar relationship was observed between chronic pain and MDD: 2¿3 sites RRR of MDD 1.59 (95%CI 1.54, 1.65); 4¿7 sites RRR of MDD 2.13 (95%CI 1.98, 2.30); widespread pain RRR of MDD 1.86 (95%CI 1.66, 2.08).Conclusions Individuals who report chronic pain and multiple sites of pain are more likely to have MDD and are at higher risk of BD. These findings highlight an important aspect of comorbidity in MDD and BD and may have implications for understanding the shared neurobiology of chronic pain and mood disorders.
Article
Full-text available
Background: The prevalence of multimorbidity (the presence of two or more long-term conditions) is rising internationally. Multimorbidity affects patients by increasing their burden of symptoms, but is also likely to increase the self-care demands, or treatment burden, that they experience. Treatment burden refers to the effort expended in operationalising treatments, navigating healthcare systems and managing relations with healthcare providers. This is an important problem for people with chronic illness such as stroke. Polypharmacy is an important marker of both multimorbidity and burden of treatment. In this study, we examined the prevalence of multimorbidity and polypharmacy in a large, nationally representative population of primary care patients with and without stroke, adjusting for age, sex and deprivation. Methods: A cross-sectional study of 1,424,378 participants aged 18 years and over, from 314 primary care practices in Scotland that were known to be demographically representative of the Scottish adult population. Data included information on the presence of stroke and another 39 long-term conditions, plus prescriptions for regular medications. Results: In total, 35,690 people (2.5%) had a diagnosis of stroke. Of the 39 comorbidities examined, 35 were significantly more common in people with stroke. Of the people with a stroke, the proportion that had one or more additional morbidities present (94.2%) was almost twice that in the control group (48%) (odds ratio (OR) adjusted for age, sex and socioeconomic deprivation 5.18; 95% confidence interval (CI) 4.95 to 5.43). In the stroke group, 12.6% had a record of 11 or more repeat prescriptions compared with only 1.5% of the control group (OR adjusted for age, sex, deprivation and morbidity count 15.84; 95% CI 14.86 to 16.88). Limitations include the use of data collected for clinical rather than research purposes, a lack of consensus in the literature on the definition of certain long-term conditions, and the absence of statistical weighting in the measurement of multimorbidity, although the latter was deemed suitable for descriptive analyses. Conclusions: Multimorbidity and polypharmacy were strikingly more common in those with a diagnosis of stroke compared with those without. This has important implications for clinical guidelines and the design of health services.
Article
Full-text available
Background Multimorbidity presents a significant public health challenge, but regional, rural/urban, and racial/ethnic differences in patterns of multimorbidity in diabetes are poorly understood. Objective To describe patterns of multimorbidity in medical and mental health by regional, rural/urban, and racial/ethnic variation in patients with type 2 diabetes mellitus. Design Retrospective cohort study from 2002 through 2006 Participants A national cohort of 892,223 veterans with diabetes Main Measures Multimorbidity was the main outcome defined as: the measure of multimorbidity and two categorical outcomes, with pattern of medical and mental health comorbidities combined and separately. Key Results Among patients, 52% had 2+ comorbidities, 33% had a single comorbidity, and 14% had no comorbidity; 13.9% had both medical and mental health comorbidities, 70.3% had medical only, and 1.5% had mental health only. The odds of having 3+ comorbidities were nearly fourfold greater in patients 75 years and older relative to patients younger than 50 years (OR=3.95 [95% CI: 3.84, 4.06]). Compared to non-Hispanic whites, the odds of 3+ comorbidities among non-Hispanic blacks were 1.67 times greater (95% CI: 1.63, 1.71). Hispanics were more likely to have a mental health comorbidity alone (OR=1.20 [95% CI: 1.13, 1.28]) than non-Hispanic whites. For patients living in rural areas, the odds were higher of having 3+ comorbidities (OR=1.21 [95% CI: 1.19, 1.23]) and of having both medical and mental health comorbidities (OR=1.15 [95% CI: 1.13, 1.17]) compared to urban dwellers. Conclusions Among individuals with diabetes, traditionally disadvantaged groups, including non-Hispanic blacks and rural patients, appear to bear the greatest burden and risk of multimorbidity. Significantly greater odds with increasing number of comorbidities were seen by race/ethnicity, rural residence, and geographic region.
Article
Cross-cultural psychology has demonstrated important links between cultural context and individual behavioural development. Given this relationship, cross-cultural research has increasingly investigated what happens to individuals who have developed in one cultural context when they attempt to re-establish their lives in another one. The long-term psychological consequences of this process of acculturation are highly variable, depending on social and personal variables that reside in the society of origin, the society of settlement, and phenomena that both exist prior to, and arise during, the course of acculturation. This article outlines a conceptual framework within which acculturation and adaptation can be investigated, and then presents some general findings and conclusions based on a sample of empirical studies.
Article
Objective: To assess the prevalence of musculoskeletal symptoms among the major ethnic minority populations of Greater Manchester. Method: The study group was a community sample of 2117 adults from the Indian, Pakistani, Bangladeshi, and African Caribbean communities. Questionnaires administered by post and by an interviewer were used to assess the presence of any musculoskeletal pain, pain in specific joints, and the level of physical function. Ethnicity was self assigned. The results were compared with those from a recent study in the local white population using the same methodology. Results: Overall response rate was 75% among the south Asian (Indian, Pakistani, and Bangladeshi community and 47% among the African Caribbean community. The profile of musculoskeletal pain among the ethnic minority groups differed from that in the white population. Although musculoskeletal symptoms were slightly more prevalent among people from ethnic minority groups than among the white population, pain in multiple sites was considerably more common among ethnic minorities. Conclusions: The finding that musculoskeletal pain is more widespread among ethnic minority communities in the UK has not previously been reported. This may reflect social, cultural, and psychological differences. The cause of the differences in the profile of pain and the health needs that follow need further investigation.
Article
Chronic pain is pathological, persisting beyond normal tissue healing time. Previous work has suggested approximately 50% variation in chronic pain development is heritable. No data are currently available on the heritability of pain categorized using the Chronic Pain Grade (CPG). Furthermore, few existing studies have accounted for potential confounders that may themselves be under genetic control or indeed 'heritable' non-genetic traits. This study aimed to determine the relative contributions of genetic, measured and shared environmental and lifestyle factors to chronic pain. Chronic pain status was determined and CPG measured in participants from Generation Scotland: the Scottish Family Health Study, a large cohort of well-characterized, extended families from throughout Scotland, UK. Heritability estimates (h (2) ) for 'any chronic pain' and 'severe' chronic pain (CPG 3 or 4) were generated using SOLAR software, with and without adjustment for shared household effects and measured covariates age,
Article
Chronic pain is pathological, persisting beyond normal tissue healing time. Previous work has suggested approximately 50% variation in chronic pain development is heritable. No data are currently available on the heritability of pain categorized using the Chronic Pain Grade (CPG). Furthermore, few existing studies have accounted for potential confounders that may themselves be under genetic control or indeed 'heritable' non-genetic traits. This study aimed to determine the relative contributions of genetic, measured and shared environmental and lifestyle factors to chronic pain. Chronic pain status was determined and CPG measured in participants from Generation Scotland: the Scottish Family Health Study, a large cohort of well-characterized, extended families from throughout Scotland, UK. Heritability estimates (h (2) ) for 'any chronic pain' and 'severe' chronic pain (CPG 3 or 4) were generated using SOLAR software, with and without adjustment for shared household effects and measured covariates age, body mass index, gender, household income, occupation and physical activity. Data were available for 7644 individuals in 2195 extended families. Without adjustment, h (2) for 'any chronic pain' was 29% [standard errors (SE) 6%; p < 0.001], and for 'severe' chronic pain was 44% (SE 3%; p <0.001). After adjustment, 'any chronic pain' h(2) = 16% (SE 7%; p = 0.02) and 'severe' chronic pain h(2) = 30% (SE 13%; p = 0.007). Co-heritability of both traits was 11% (SE 76%). This study supports the use of chronic pain as a phenotype in genetic studies, with adequate correction for confounders to specifically identify genetic risk factors for chronic pain
Article
Cognitive impairment is a common feature of schizophrenia; however, its origin remains controversial. Neurodevelopmental abnormalities clearly play a role in pre-morbid cognitive dysfunction in schizophrenia, yet many authors believe that schizophrenia is characterized by illness-related cognitive decline before and after onset of the psychosis that can be the result of neurodegenerative changes. The main reasons behinds such arguments include, first, the evidence showing that effect sizes of the cognitive deficits in subjects who develop adult schizophrenia gradually increase in the first two decades of life and, second, the fact that there is functional decline in many patients with schizophrenia over the years. In this Editorial, I argue that current evidence suggests that illness-related cognitive impairment is neurodevelopmental in origin and characterized by slower gain (developmental lag) but not cognitive decline continuing throughout the first two decades of life. I introduce a model suggesting that neurodevelopmental abnormality can in fact explain the course of cognitive dysfunction and variations in the trajectory of functional decline throughout the life in individuals with schizophrenia. In this model, the severity of underlying neurodevelopmental abnormality determines the age that cognitive deficits first become apparent and contributes to the cognitive reserve of the individual. Interaction of neurodevelopmental abnormality with clinical symptoms, especially negative symptoms and aging, vascular changes, psychological and iatrogenic factors contributes to the heterogeneity of the functional trajectory observed in this disorder.
Article
Widening inequality in the distribution of resources, higher rates of unemployment and deteriorating conditions in the inner cities have concentrated attention in Britain, and elsewhere in Europe, upon the idea and exact meaning of ‘deprivation’. This scientific concept is used extensively not only in the analysis of social conditions but also, in an applied form, as an instrument of policy in allocating resources to particular regions, areas and services. This paper argues that the indicators which are chosen to represent the phenomenon are often unduly restricted and even involve double counting. As a result the distribution and severity of deprivation seems to be seriously misperceived and resources misallocated. A review of the available studies shows how the concept might be treated more coherently in relation to that of poverty.